Understanding how ECRG4 helps the body fight Staph Aureus infections
The role of the ECRG4 in Host Defense of Staph Aureus Infection
This study is looking at how a protein called ECRG4 can help boost the immune system's ability to fight skin infections caused by Staph Aureus, especially the tough MRSA strain, with the hope of finding better treatments for patients dealing with these infections.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10876441 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called ECRG4 in enhancing the body's immune response to skin infections caused by Staph Aureus, particularly the antibiotic-resistant strain known as MRSA. The study focuses on how ECRG4 influences the recruitment and activation of neutrophils, which are crucial white blood cells in fighting infections. By exploring the mechanisms of ECRG4, the research aims to develop new therapies that could improve the body's ability to combat these infections. Patients may benefit from advancements in treatment options that target these immune pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from skin and soft tissue infections, particularly those caused by MRSA.
Not a fit: Patients with infections not caused by Staph Aureus or those who do not have skin infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that enhance the immune response against antibiotic-resistant skin infections.
How similar studies have performed: Previous research has shown promise in targeting immune mechanisms for improving responses to infections, suggesting that this approach could be effective.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Dorschner, Robert a — University of California, San Diego
- Study coordinator: Dorschner, Robert a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.